Complex Carbohydrates Come to Chemoresistance
Selectin Blocker Can Protect Blood Stem Cells from Chemo
By Anette Breindl
Wednesday, October 24, 2012
Researchers from the Australian Mater Medical Research Institute, the University of Brisbane and U.S. biotech company GlycoMimetics Inc. have reported new insights into how blood stem cells are activated by selectins, and how blocking that activation may be able to protect them from the effects of chemotherapy and radiation.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.